Online GLP-1 Programs in Maryland
Maryland is the nineteenth-largest state and, despite expanding Medicaid, does not cover GLP-1s for weight loss. The state's Medicaid GLP-1 spending is among the highest in the nation, and proposals to add obesity coverage have stalled over cost, leaving cash-pay and telehealth as the main routes.
Population
6.3M
19th-largest state
Adult obesity
32.7%
2024 BRFSS
Diagnosed diabetes
12.4%
2024 BRFSS
Medicaid (weight loss)
Not coveredFrom $129/mo · Ships in 2–4 days · Sponsored
Insurance
Does Maryland Medicaid cover GLP-1s?
Maryland Medicaid does not cover GLP-1s for weight loss as a general benefit (RX Index, 2026). It does cover them for type 2 diabetes, and federal rules require coverage for non-obesity indications such as Wegovy's cardiovascular use and Zepbound's sleep-apnea use, so partial access exists through those qualifying conditions. Bills to add obesity coverage (SB 496) have not advanced, with the state projecting a cost of $225 million to $438 million a year.
Online Access
Getting a GLP-1 online in Maryland
GLP-1s are not controlled substances, so Maryland allows them to be prescribed via telehealth when a Maryland-licensed clinician completes an appropriate evaluation (Maryland Board of Physicians). Online programs can serve residents statewide through a Maryland-licensed prescriber.
Compounding
Compounded semaglutide & tirzepatide in Maryland
Routine compounding of semaglutide and tirzepatide ended after the FDA resolved the shortages in early 2025 (FDA, 2025). Maryland adds no special carve-out beyond the federal 503A/503B framework, so compounding is limited to documented, patient-specific clinical need.
Demand
Where GLP-1 demand is highest in Maryland
About 33% of Maryland adults have obesity and roughly 12% have diagnosed diabetes (CDC BRFSS via America's Health Rankings, 2024). Demand concentrates in the populous Washington, D.C. suburbs of Montgomery and Prince George's counties and in the Baltimore area. Maryland Medicaid already spends more than $68 million a year on GLP-1s, among the highest of any state, which is exactly why adding weight-loss coverage has stalled over cost (Baltimore Sun, 2024).
Questions
Maryland GLP-1 FAQ
Does Maryland Medicaid cover Wegovy or Zepbound?
Not for weight loss. Maryland Medicaid covers GLP-1s for type 2 diabetes and, as federal law requires, for non-obesity indications like Wegovy's cardiovascular use and Zepbound's sleep apnea. A bill to add weight-loss coverage has not advanced over cost (RX Index, 2026).
Can I get a GLP-1 prescribed online in Maryland?
Yes, by a Maryland-licensed clinician. GLP-1s are not controlled substances, so standard telehealth standard-of-care rules apply.
Is compounded tirzepatide available in Maryland?
Only narrowly. Routine compounding ended after the FDA resolved the shortages in 2025, and Maryland follows the federal rules with no special carve-out.
Compound Guides
The GLP-1s behind these programs
Sources
How we sourced this page
Coverage, prevalence, and policy figures are drawn from primary and authoritative sources, last reviewed June 2026.
- 1.The RX Index — Medicaid GLP-1 coverage by state (2026)
- 2.KFF — Medicaid Coverage of and Spending on GLP-1s (Jan 2026)
- 3.Baltimore Sun — Maryland Medicaid GLP-1 spending (2024)
- 4.America's Health Rankings — Maryland obesity (CDC BRFSS 2024)
- 5.Maryland Board of Physicians — telehealth FAQs
- 6.FDA — Compounding policy as GLP-1 supply stabilizes (2025)
Telehealth, no insurance needed
Personalized GLP-1 for Maryland residents
Skip the coverage maze. Yucca Health connects Maryland residents with US-licensed clinicians for personalized GLP-1 treatment, from $129/mo.
See if you qualifySponsored · Affiliate disclosure
Educational information only, not medical or legal advice and not a substitute for a licensed clinician. GLP-1 coverage, telehealth, and compounding rules vary by state and change frequently; verify the current rules for your state before starting treatment. Links to Yucca Health are sponsored. Last reviewed 2026-06-13.